Summary Taxol, a unique tubulin active agent, was found to demonstrate a marked schedule-dependent synergistic interaction with cisplatin (DDP) in the killing of human ovarian carcinoma 2008 cells in vitro as determined by median effect analysis. The interaction was highly synergistic when 19 h taxol exposure was followed by I h concurrent exposure to taxol and DDP. The combination indices (CIs) on this schedule were 0.11 ± 0. 1, 0.25 + 0.15 and 0.39 ± 0.14 at 20%, 50% and 80% cell kill respectively. However, the interaction was antagonistic when 1 h exposure to DDP was followed by 20 h exposure to taxol, or when cells were exposed to DDP and taxol for 1 h concurrently. When taxol preceded DDP, synergy was also observed with the 11-fold DDP-resistant 2008/C 13*5.25 subline, which yielded CI values of 0.21 ± 0.02, 0.30 ± 0.11 and 0.31 ± 0.17 at 20%, 50% and 80% cell kill respectively. At an IC50 concentration, taxol had no effect on [3H]cis-dichloro(ethylenediamine) platinum uptake, on the permeability of the plasma membrane or on glutathione or metallothionein levels in 2008 or 2008/C13*5.25 cells. Mitotic arrest in these cells was observed only at taxol concentrations well above those required for synergy with DDP, suggesting that the mechanism underlying the synergistic interaction was not a taxol-induced alteration in cell cycle kinetics. Of additional interest was the fact that the 2008/Cl3*5.25 cells were hypersensitive to taxol, and that this was partially explained by an alteration in the biochemical pharmacology of taxol. Although cellular taxol accumulation reached steady state within 2 h in both cell lines, taxol efflux was slower and the taxol was more extensively bound in 2008/C13*5.25 cells than in 2008 cells. In addition, the 2008/C13*5.25 cells had only 55% of the parental levels of P-tubulin content. However, in another pair of DDP-sensitive and -resistant ovarian cell lines no taxol hypersensitivity and no change in P-tubulin content was observed, indicating that the DDP-resistant and taxol-hypersensitive phenotypes do not segregate together. We conclude that taxol interacts synergistically with DDP in a manner that is highly schedule dependent, and that the hypersensitivity of 2008/C13*5.25 cells to taxol is unrelated to the mechanism of synergy. These in vitro observations suggest that drug schedule will be an important determinant of the activity and toxicity of the DDP and taxol drug combination in clinical studies.
DDP3 often produces good initial therapeutic responses in ovarian carcinoma, but resistance to DDP develops frequently, leading to chemotherapeutic failure. The mechanisms reported to be capable of mediating DDP resistance include increased cellular glutathione, increased metallothionein, decreased drug uptake and Pt-DNA adduct formation, and enhanced DNA repair (Andrews & Howell, 1990) . Because of the clinical importance of DDP, there has been wide interest in identifying agents that synergistically modulate DDP activity at the cellular level. Only a few such agents are known. Synergistic interactions have been reported for DDP with cytarabine (Andrews et al., 1988; Keane et al., 1990) , 2'-deoxy-5-azacytidine (Frost et al., 1990) , and alkylating agents (Frost et al., 1990; Lidor et al., 1991; Hayward et al., 1992) . Anguidine (Hromas et al., 1984) and forskolin (Mann et al., 1991) have been noted to enhance the cellular uptake of DDP, whereas uptake is blocked by aldehydes (Dornish & Pettersen, 1985; Dornish et al., 1986) and ouabain (Andrews et al., 1988) . Dipyridamole has been identified as another agent capable of enhancing sensitivity to DDP (Keane et al., 1990; Jekunen et al., 1992) . Furthermore, quercetin, tamoxifen and staurosporin have been found to interact synergistically with DDP in Walker rat carcinoma cells (Hofmann et al., 1989) . The new phospholipid analogue BM41440 inhibits protein kinase C and is reported to demonstrate synergy with DDP (Hofmann et al., 1989) .
Anti-microtubule agents are among the most important anti-cancer drugs, and have significantly contributed to the therapy of most curable neoplasms, such as Hodgkin's and non-Hodgkin's lymphomas, germ cell tumours and childhood leukaemias. While other anti-microtubule agents induce microtubule disassembly, taxol promotes microtubule assembly. Taxol has demonstrated a broad anti-tumour spectrum in preclinical studies (McQuire et al., 1989; , and is active against DDP-unresponsive advanced ovarian cancer, with a reported response rate of 24-33% in phase II studies (Einzig et al., 1990) .
Several studies of the combination of DDP and taxol for the treatment of ovarian carcinoma are currently under way. The goal of this study was to investigate the nature of the interaction between DDP and taxol, and to determine whether the interaction demonstrated any schedule dependency. We report here that there is a highly synergistic interaction between these two drugs, but that the synergy is also highly schedule dependent.
Materials and methods

Cell lines
Experiments were conducted using the human ovarian carcinoma line 2008 (DiSaia et al., 1972 and an 11-fold DDPresistant (2008/C 13*5.25) subline generated by monthly incubation in DDP (Andrews et al., 1985) . The human ovarian carcinoma A2780 and A2780CP cell lines were supplied by R. Ozols (Fox Chase Cancer Institute, Philadelphia, PA, USA). Cells were maintained in RPMI-1640 supplemented with 5% fetal bovine serum and 2 mM L-glutamine without antibiotics. Cultures routinely tested negative for mycoplasma by using Gen Probe kit (Gen Probe, San Diego, CA, USA).
triplicate at a density of 300 cells per dish. Cells were exposed to taxol for 19 h and then, while the taxol exposure continued, to DDP for an additional hour. Alternatively, after allowing cells to attach overnight, cultures were exposed to either taxol and DDP concurrently, or first to DDP for 1 h and then to taxol for 20 h. Cells were incubated in 5% carbon dioxide at 37°C for 10 days, and then fixed with methanol and stained using Giemsa dye in methanol. Clusters of more than 40 cells were counted as one colony; control dishes generally contained 100-130 colonies.
Median effect analysis The nature of the interaction between DDP and taxol was assessed by median effect analysis (Chou & Talalay, 1986; Berenbaum, 1989 
Electron microscopy
Monolayer cells were treated with 10 nM taxol for 24 h, then fixed first in 2.5% (v/v) glutaraldehyde in 0.1 M sodium phosphate buffer (pH 7.4, total osmolarity 0.52 osmol) and then in 1 % osmium tetroxide. Sections were cut parallel to the culture surface on an LKB-V ultramicrotome (Pharmacia LKB Biotechnology, Piscataway, NJ, USA). Thin sections were stained with saturated uranyl acetate in 50% (v/v) ethanol and then with bismuth subnitrate (Riva, 1974) . Cells were viewed with an H-600 transmission electron microscope (Hitachi Instruments, Danbury, CT, USA). Sections of control and taxol-treated cells taken parallel to the plane of the tissue culture dish were used to estimate the volume density of microtubule bundles by point counting (Weibel, 1979; Mathieu-Costello, 1987) . Measurements were made at a final magnification of 16,200 by placing a transparent overlay of a 400 point grid on random micrographs of cell sections taken in the region of the nucleus. Four sections of four random micrographs were analysed for each condition.
Intracellular pharmacology of taxol Taxol uptake was determined using [3H]taxol. One million cells were seeded in 60 mm tissue culture dishes, and after 3 days, when cell cultures were in log phase growth, the influx and efflux of taxol was determined. The medium was aspirated, and fresh medium containing 0.1I,Ci ml-' (27.8 nM) taxol was added for appropriate times to determine influx. Cells were then washed three times with ice-cold PBS. One millilitre of 1 nM sodium hydroxide was added and the cells allowed to digest overnight. An aliquot was removed for the determination of protein content by the method of Bradford (1976) and 0.5 ml was used for liquid scintillation counting.
In experiments designed to quantitate efflux, cells were first loaded by incubating them in taxol (27.8 nM, 0.1 ,uCi ml-') for 2 h, and then the medium was aspirated and fresh medium containing no taxol was added. Effect of taxol on cellular permeability The effect of taxol on plasma membrane permeability was tested by trypan blue exclusion. Log-phase cells were trypsinised and resuspended at 500,000 cells ml-' in trypan blue-containing fresh medium to which taxol had been added. Cell staining after treatment with 10 nM, 100 nM and 1 !LM taxol was followed by microscopy over 5 min. Further experiments were done by adding trypan blue following a 20 h incubation with 100 nM and 1 iLM taxol, and subsequently examining the cells for uptake of trypan blue.
Effect of taxol on cell cycle phase distribution Cells in the log phase of growth were exposed to 0, 10, 100 nM and 2 tM taxol for 20 h, then harvested by trypsinisation, washed in PBS containing 2 mM magnesium chloride, and fixed by adding 10 ml of 70% ethanol. Thereafter, cells were kept at 4°C until flow cytometric analysis. Cells were resuspended in 50 tLM propidium iodide and 1,000 units ml-l RNAse A in PBS, incubated at 37°C for 30 min, and analysed on a Cytofluorograf (Ortho Diagnostics Systems, Raritan, NJ. USA). Multicycle Cell Cycle Software (Phoenix Flow Systems, San Diego, CA, USA) was used to calculate the fraction of cells in each phase of the cell cycle. This programme is based on the mathematical model described by Dean and Jett (1974) , using Gaussian distribution functions for G, and G2/M phases, and a broadened second-degree polynomial for S-phase. To assess the percentage of cells in M-phase, a method based on difference in chromatin structure was used (Darzynkiewicz et al., 1977a,b) . After fixation and treatment with RNAse, cells were treated with acid and stained with the metachromatic fluorochrome acridine orange (Larsen et al., 1986) . The extent of DNA denaturation per cell was estimated from the ratio of red to green fluorescence intensity. Metaphase and interphase cells were discriminated on the basis of their red/green intensity ratios after partial DNA denaturation. (Davis et al., 1986; Sambrook et al., 1989) . Membranes were hybridised sequentially with 32p_ labelled cDNA probes for human metallothionein II (Karin & Richards, 1982) and 0-actin (Gunning et al., 1983) , the latter used to control for lane loading.
Quantitation of tubulin subunits
Monoclonal antibodies directed against a-and P-tubulin were used to quantitate tubulin subunits. Cells were harvested by trypsinisation, fixed in 37% (v/v) formaldehyde in PBS (pH 7.4) for 10 min at room temperature and permeabilised with 0.1% saponin in PBS for 5 min. Cells were incubated with 100 nM monoclonal antibody in 3% bovine serum albumin in PBS. After washing, the cells were stained with a fluorescent goat anti-mouse IgG/IgM antibody for 45 min in the dark, and then analysed on a CytoFluorograf (Ortho Diagnostics Systems, Raritan, NJ, USA) with excitation and emission settings of 488 and 530 nM respectively.
Results
Interaction between DDP and taxol Figure 1 shows the clonogenic survival curves for DDP alone, taxol alone, and the combination of DDP and taxol at a fixed molar ratio of 7,500:1. The more negative slope of the curve for the combination suggests an interaction between the two drugs, but the nature of the interaction could not readily be discerned since both agents were independently cytotoxic (Berenbaum, 1989) .
The nature of the interaction between taxol and DDP was determined by using median effect analysis (Chou & Talalay, 1986) , which provides a tool to examine the degree of synergy, additivity or antagonism at various levels of cell kill. Median effect analysis permits calculation of the CI at various levels of cell kill. CI values of 1 indicate additivity, values of <1 synergy and values of > 1 antagonism; the smaller the value of the CI below 1 the greater the degree of synergy, and the greater the value above 1 the greater the antagonism. Figure 2 shows the CI plot for some three separate experiments as shown in Figure 1 in which DDP and taxol were combined in a ratio of 7,500:1, which was the ratio of their individual IC50 values. The curve demonstrates synergy between DDP and taxol in the killing of 2008 cells under conditions in which the cells were first treated with taxol for 19 h and then with DDP and taxol concurrently for 1 h. At the 20% level of cell kill, the average CI was 0.11 ± 0.1 (s.e.m.; n = 3), indicating synergy. At the 50% level of cell kill the mean CI was 0.25 ± 0.15 (s.e.m.; n = 3), and it was 0.39 ± 0.14 (s.e.m.; n = 3) at the 80% level of cell kill. The CI was significantly less than 1 (P<0.05) at all three levels of cell kill, and these values indicate a very strongly synergistic interaction. Figure 3 shows the CI plot for the DDP-resistant 2008/ Cl3*5.25 cells also exposed to DDP and taxol in a ratio of 250:1 using the same schedule of pretreatment with taxol for 19 h followed by 1 h concurrent exposure to taxol and DDP. Interestingly, these DDP-resistant cells were 5-fold hypersensitive to taxol. and 80% cell kill respectively. Thus, synergy was evident and was statistically significant (P <0.05) over a range of 1 log of cell kill in both cell lines, and hypersensitivity to taxol did not affect the nature of the interaction between DDP and taxol. Figure 4 presents the CI curve for 2008 cells when the same ratio of drugs was employed but on a schedule in which the cells were first exposed to DDP for 1 h, following which the medium was changed and the cells exposed to taxol for 20 h. This treatment schedule resulted in substantial antagonism instead of the synergy over the first 2 logs of cell kill. Figure 5 shows the CI plot resulting from experiments in which 2008 cells were exposed concurrently to DDP and taxol for only I h. On this schedule, the IC50 concentrations for DDP and taxol were 2.5 pM and 50 nM, and because of limits on the solubility of taxol the experiments were performed at a DDP/taxol concentration ratio of 50:1. The CI plot indicates antagonism between the two drugs on this schedule.
Effect of taxol on glutathione levels The effect of a 20 h pretreatment with an IC50 concentration of taxol on the GSH content of 2008 and 2008/C13*5.25 cells is shown in Table I . The GSH levels were 2-fold higher in the DDP-resistant cells (P = 0.00098, two-tailed unpaired t-test), but taxol pretreatment did not alter the glutathione level in either line. Effect of taxol on cell cycle phase distribution Sensitivity to DDP varies in different phases of the cell cycle, being greatest in GI (Roberts & Fravel, 1980 t-test), while a-tubulin content is unchanged (Christen et al., 1993) . To determine whether hypersensitivity to taxol was a consistent feature of the DDP-resistant phenotype in ovarian carcinoma cell lines, we examined the taxol sensitivity of another pair of DDP-sensitive and -resistant human ovarian carcinoma cells, A2780 and A2780CP cells. While the A2780CP cells are 6-fold resistant to DDP, they showed no difference in sensitivity to taxol using a 20 h exposure (Figure 8 ). In addition, they showed no abnormality of tubulin content. The A2780cP cells contained 92 ± 17% and 95 ± 13%, respectively, of the a-and ,B-tubulin present in the parental 2780 Administration of taxol before DDP was result in greater anti-tumour activity thar schedule when tested against L1210 murine leu vitro by Citardi et al. (1990) . In these cells, a to taxol followed by a 30 min exposure to greater cell kill than either concurrent exposure or a sequence consisting of a 30 min expo followed by a 24 h exposure to taxol. The relat values in the presence of taxol were 28%, 100' those for DDP alone on the three schedules. F (1991) showed in a phase I trial that myelosi less profound when taxol was given prior to with the reverse schedule. However, this differe was associated with a higher clearance of tax( given before rather than after DDP, and the drug on the sensitivity to the other at the cellu not be assessed. Nevertheless, based on ti sequence of taxol administered prior to DDP M further clinical development (Weinstein & Solomon, 1990) . Overexpression of ,B-tubulin resulted in loss of normal microtubular structures and viability, but an excess of a-tubulin over P-tubulin was not toxic (Weinstein & Solomon, 1990) . Given that the ratio ofa-to ,B-tubulin was no different in the A2780CP than in the A2780 cells, whereas the amount of P-tubulin in 2008/C13*5.25 cells was decreased relative to that of a-tubulin (Christen et al., 1993) , it is conceivable that the, response to taxol was also altered.
Peak plasma concentrations of taxol range from a mean of 0.95 LM for 275mg m-2 given as a constant rate infusion over 24h to >8 tM when given at a dose of 275 mgm-2 over 6 h (Wiernik et al., 1987a,b) . Thus, the attainable plasma concentrations of taxol are well above the range necessary to demonstrate synergistic killing when combined with DDP. The schedule-dependent synergy between these two drugs will further complicate the clinical assessment of combination taxol/DDP therapy for patients with ovarian cancer
